US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

317.20

+12.294.03%

Pre-market: 316.60-0.6000-0.19%07:27 EDT

Volume:468.50K

Turnover:149.84M

Market Cap:673.89M

PE:- -

High:329.20

Open:311.70

Low:306.27

Close:304.91

52wk High:341.93

52wk Low:66.60

Shares:2.12M

Float Shares:2.12M

Volume Ratio:0.98

T/O Rate:22.05%

Dividend:1.02

Dividend Rate:0.32%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Modern Healthcare Technology Details Higher Audit Fee in KPMG Reappointment Plan

Analysts’ Top Healthcare Picks: Neurocrine (NBIX), Aquestive Therapeutics (AQST)

iWOW Shareholders Back S$15 Million Share Placement to Fund Healthcare Nutrition Expansion

Aveanna Healthcare Raises 2026 Outlook After Strong Quarter

Aveanna Highlights Growth and Scale in Investor Presentation

Press Release: ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Elanco Animal Health (ELAN), Liquidia Technologies (LQDA) and GE Healthcare Technologies Inc (GEHC)

Press Release: Beyond Air(R) Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

Press Release: Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance

Rici Healthcare Sets Board Meeting to Review Interim Results and Dividend

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sutro Biopharma (STRO), Summit Therapeutics (SMMT) and Altimmune (ALT)

Health Care Roundup: Market Talk

Youcare Pharmaceutical's Unit Gets US FDA's Nod to Trial YKYY033 Injection

MT Newswires Live

Aurisco Pharmaceutical Subsidiary's Worksops Pass US FDA Inspection; Shares Rise 3%

MT Newswires Live

Promisia Sets AGM to Seek Shareholder Approval for $25m Chatswood Acquisition

Promisia Wins NZX Waivers for $25m Chatswood Aged Care Acquisition

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT)

Belite Bio (BLTE) Is Up 12.9% After FDA Priority Review For Tinlarebant In Stargardt Disease

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=14"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":317.2,"timestamp":1787342400000,"preClose":304.91,"halted":0,"volume":468504,"hourTrading":{"tag":"盘前","latestPrice":316.6,"preClose":317.2,"latestTime":"07:27 EDT","volume":484,"amount":153988.84952,"timestamp":1787570860256,"change":-0.6,"changeRate":-0.001892,"amplitude":0.014833},"delay":0,"changeRate":0.04030697582893301,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Pre-Mkt","change":12.29,"latestTime":"08-24 07:31:25 EDT","open":311.7,"high":329.2026,"low":306.27,"amount":149839169.98896,"amplitude":0.075211,"askPrice":318,"askSize":200,"bidPrice":315,"bidSize":1,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":317.2,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.0032,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":316.6,"preClose":317.2,"latestTime":"07:27 EDT","volume":484,"amount":153988.84952,"timestamp":1787570860256,"change":-0.6,"changeRate":-0.001892,"amplitude":0.014833},"postHourTrading":{"tag":"盘后","latestPrice":317.87,"preClose":317.2,"latestTime":"19:58 EDT","volume":6645,"amount":2111082.7734,"timestamp":1787356729854,"change":0.67,"changeRate":0.002112,"amplitude":0.006526},"volumeRatio":0.9815516107169615,"impliedVol":0.9442,"impliedVolPercentile":0.672},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9815516107169615,"shares":2124486,"dividePrice":1.015,"high":329.2026,"amplitude":0.075211,"preClose":304.91,"low":306.27,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":317.2,"committee":-0.99005,"eps":0,"divideRate":0.0032,"volume":468504,"delay":0,"ttmEps":0,"open":311.7,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":276.54,"twentyDayClose":245.6,"sixtyDayClose":186},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:14,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659678152","title":"Modern Healthcare Technology Details Higher Audit Fee in KPMG Reappointment Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2659678152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659678152?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:37","pubTimestamp":1786624671,"startTime":"0","endTime":"0","summary":"An update from Modern Healthcare Technology Holdings Limited ( ($HK:0919) ) is now available. Modern Healthcare Technology Holdings Limited has iss...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/modern-healthcare-technology-details-higher-audit-fee-in-kpmg-reappointment-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/modern-healthcare-technology-details-higher-audit-fee-in-kpmg-reappointment-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0029874061.USD","XLV","HCSG","BK4137","LU0128526141.USD","BK4585","LABU","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659154461","title":"Analysts’ Top Healthcare Picks: Neurocrine (NBIX), Aquestive Therapeutics (AQST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659154461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659154461?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:20","pubTimestamp":1786623610,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neurocrine (NBIX), Aquestive Therapeutics (AQST) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-neurocrine-nbix-aquestive-therapeutics-aqst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-neurocrine-nbix-aquestive-therapeutics-aqst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2065171311.SGD","BK4137","LU0154245756.USD","LU0109394709.USD","AQST","LABU","NBIX","LU0320765992.SGD","LU0029874061.USD","HCSG","LU2065169927.USD","BK4007","BK4588","LU0154245673.USD","LU0889565916.HKD","XBI","BK4139","LU2324357040.USD","XLV","LU0823416689.USD","BK4581","LU2065170008.USD","LU2065171402.SGD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151337","title":"iWOW Shareholders Back S$15 Million Share Placement to Fund Healthcare Nutrition Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151337","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151337?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:39","pubTimestamp":1786621151,"startTime":"0","endTime":"0","summary":"The latest update is out from iWOW Technology Limited ( ($SG:NXR) ). iWOW Technology Limited convened an extraordinary general meeting on 16 July 2...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/iwow-shareholders-back-s15-million-share-placement-to-fund-healthcare-nutrition-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/iwow-shareholders-back-s15-million-share-placement-to-fund-healthcare-nutrition-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0029874061.USD","HCSG","XBI","BK4209","BK4137","BK4581","XLV","LABU","BK4588","SG","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151333","title":"Aveanna Healthcare Raises 2026 Outlook After Strong Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151333","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151333?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:36","pubTimestamp":1786620999,"startTime":"0","endTime":"0","summary":"An announcement from Aveanna Healthcare Holdings ( ($AVAH) ) is now available. Aveanna Healthcare Holdings reported strong financial results for th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-raises-2026-outlook-after-strong-quarter?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-raises-2026-outlook-after-strong-quarter?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4539","BK4585","HCSG","BK4588","LU0029874061.USD","XBI","AVAH","LU0128526141.USD","BK4581","BK4137","BK4196","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151368","title":"Aveanna Highlights Growth and Scale in Investor Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151368?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:36","pubTimestamp":1786620975,"startTime":"0","endTime":"0","summary":"Aveanna Healthcare Holdings ( ($AVAH) ) has shared an announcement. On August 13, 2026, Aveanna Healthcare Holdings Inc. released an investor prese...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aveanna-highlights-growth-and-scale-in-investor-presentation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aveanna-highlights-growth-and-scale-in-investor-presentation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVAH","BK4581","BK4585","BK4539","XLV","XBI","BK4588","LABU","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159750","title":"Press Release: ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159750","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159750?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620600,"startTime":"0","endTime":"0","summary":"Second quarter 2026 net product revenue of $18.6 million; cash and cash equivalents of $219.1 million as of June 30, 2026LOTIS-7, LOTIS-5 and MZL IIT data submitted for presentation at ASHCompany eval","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4588","BK4231","LU2463526074.USD","BK4139","BK4109","ASH","BK4022","BK4211","ADC","LENZ","PFS","BK4585","BK4539","BK4080","LABU","NETL","BK4232","BK4007","BK4505","BK4195","ADCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659315159","title":"Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619422,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Monte Rosa Therapeutics (GLUE), Mineralys Therapeuti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4539","BK4588","LU0029874061.USD","ADAG","MLYS","BK4585","LABU","GLUE","LU0128526141.USD","XBI","BK4137","HCSG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156302","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Elanco Animal Health (ELAN), Liquidia Technologies (LQDA) and GE Healthcare Technologies Inc (GEHC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156302","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156302?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618844,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Elanco Animal Health (ELAN), Liquidia Technologies...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-elanco-animal-health-elan-liquidia-technologies-lqda-and-ge-healthcare-technologies-inc-gehc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-elanco-animal-health-elan-liquidia-technologies-lqda-and-ge-healthcare-technologies-inc-gehc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2168564149.EUR","XAR","PPA","LU1551013342.USD","EXI","LU0689472784.USD","LU2168564065.EUR","LU1064131342.USD","LU1988902786.USD","LABU","LU1280957306.USD","LU0820562030.AUD","GE","LU0868494617.USD","MISL","LU1066051498.USD","BK4082","LU2087625088.SGD","LU2168563687.JPY","LGHT","LU1093756168.USD","UXI","LU1119994496.HKD","ELAN","LQDA","LU0149725797.USD","LU2756315318.SGD","LU0354030511.USD","NATO","LU1941712348.USD","LU2168564495.EUR","TRUI","LU0267386448.USD","BK4206","LU0124676726.USD","LU1066051811.HKD","LU1093756325.SGD","LU1551013425.SGD","GEHC","LU0077335932.USD","DFEN","LU1261432733.SGD","LU0943347566.SGD","XLV","XBI","ITA","LU1066053197.SGD","LU2756315664.SGD","LU1066051225.USD","LU0353189680.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659568431","title":"Press Release: Beyond Air(R) Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659568431","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659568431?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"partners.Financial Results for the Quarter Ended June 30, 2026Revenues for the quarters ended June 30, 2026 and 2025 were $1.8 million.Gross margins for the quarter ended June 30, 2026 were 13%, compared to 9% for the same period last year.Research and development expenses for the quarter ended June 30, 2026 were $2.0 million, compared with $3.1 million for the same period last year.Selling, general and administrative expenses for the quarter ended June 30, 2026 were $4.9 million, compared with $4.7 million for the same period last year.Other expense for the quarter ended June 30, 2026 was $1.5 million, compared with $0.5 million for the same period last year.Net loss attributable to co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","LABU","BK4585","BK4588","XAIR","BK4082","BK4232","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659515632","title":"Press Release: Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2659515632","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659515632?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"-- Second Quarter Revenue was $670.5 million, a 13.7% increase over the. -- Second Quarter Net income was $40.3 million compared to $27.0 million for. -- Adjusted EBITDA for Q2 2026 was $95.4 million, an 8.0% increase over the. -- Increased Full Year 2026 Revenue guidance to greater than $2.68 billion,-- Increased Full Year 2026 Adjusted EBITDA guidance to greater than","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4196","XLV","BK4588","BK4585","XBI","AVAH","LABU","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659130502","title":"Rici Healthcare Sets Board Meeting to Review Interim Results and Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2659130502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659130502?lang=en_us&edition=fundamental","pubTime":"2026-08-13 17:21","pubTimestamp":1786612872,"startTime":"0","endTime":"0","summary":"Rici Healthcare Holdings Ltd. ( ($HK:1526) ) just unveiled an announcement. Rici Healthcare Holdings Ltd. has scheduled a board meeting for August ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rici-healthcare-sets-board-meeting-to-review-interim-results-and-dividend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rici-healthcare-sets-board-meeting-to-review-interim-results-and-dividend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4585","HCSG","LU0029874061.USD","XBI","LU0128526141.USD","BK4588","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659320171","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Sutro Biopharma (STRO), Summit Therapeutics (SMMT) and Altimmune (ALT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659320171","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659320171?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:30","pubTimestamp":1786609840,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sutro Biopharma (STRO), Summit Therapeutics (SMMT)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sutro-biopharma-stro-summit-therapeutics-smmt-and-altimmune-alt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sutro-biopharma-stro-summit-therapeutics-smmt-and-altimmune-alt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALT","BK4581","HCSG","BK4585","LU2488822045.USD","BK4137","LU0128526141.USD","LU0029874061.USD","LU1878469433.USD","SMMT","XLV","BK4139","XBI","STRO","BK4588","BK4599","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659132316","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2659132316","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659132316?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:20","pubTimestamp":1786609200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0104 GMT - KPJ Healthcare could post sequentially stronger 2Q co","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4588","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659390131","title":"Youcare Pharmaceutical's Unit Gets US FDA's Nod to Trial YKYY033 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2659390131","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659390131?lang=en_us&edition=fundamental","pubTime":"2026-08-13 15:14","pubTimestamp":1786605248,"startTime":"0","endTime":"0","summary":"Youcare Pharmaceutical's  unit, Beijing Youcare Kechuang Pharmaceutical Technology, received approval from the U.S. Food and Drug Administration to proceed with the clinical trial of YKYY033 injection, according to a Shanghai bourse filing on Thursday.The drug will be tested as a prevention and treatment for arterial and venous thrombosis.The Chinese pharmaceutical company's shares rose 1% during the afternoon trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","688658","LABU","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659136720","title":"Aurisco Pharmaceutical Subsidiary's Worksops Pass US FDA Inspection; Shares Rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659136720","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659136720?lang=en_us&edition=fundamental","pubTime":"2026-08-13 14:30","pubTimestamp":1786602629,"startTime":"0","endTime":"0","summary":"Aurisco Pharmaceutical  subsidiary Yangzhou Aurisco Pharmaceutical's quality management system passed an inspection by the U.S. Food and Drug Administration, according to a Thursday filing with the Shanghai bourse.The FDA inspected Yangzhou Aurisco's workshops in Jiangsu, China from June 15 to 19, covering its production facilities and found the workshops to be in compliance with current good manufacturing practice standards, the filing said.Shares rose 3% during afternoon trading on Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK0239","LABU","605116","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659133316","title":"Promisia Sets AGM to Seek Shareholder Approval for $25m Chatswood Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2659133316","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659133316?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:17","pubTimestamp":1786598245,"startTime":"0","endTime":"0","summary":"Promisia Healthcare Limited ( ($NZ:PHL) ) has issued an announcement. Promisia Healthcare has called its 2026 annual shareholders’ meeting for 27 A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/promisia-sets-agm-to-seek-shareholder-approval-for-25m-chatswood-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/promisia-sets-agm-to-seek-shareholder-approval-for-25m-chatswood-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4195","BK4581","BK4585","XLV","BK4229","XBI","BK4588","AGM","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659318133","title":"Promisia Wins NZX Waivers for $25m Chatswood Aged Care Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2659318133","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659318133?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:17","pubTimestamp":1786598236,"startTime":"0","endTime":"0","summary":"The latest update is out from Promisia Healthcare Limited ( ($NZ:PHL) ). NZ RegCo has granted Promisia Healthcare Limited waivers from NZX Listing ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/promisia-wins-nzx-waivers-for-25m-chatswood-aged-care-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/promisia-wins-nzx-waivers-for-25m-chatswood-aged-care-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","NZ20C.NZ","BK4588","BK8020","TNZ.NZ","NZX.NZ","NZT.NZ","T10G.NZ","NZ50G.NZ","BK4585","LABU","NZG.NZ","XBI","FNZ.NZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659187819","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659187819","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659187819?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:30","pubTimestamp":1786588220,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH). CG Onc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cg-oncology-inc-cgon-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cg-oncology-inc-cgon-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0792757196.USD","LU0708994859.HKD","LU0006061336.USD","LU0029864427.USD","LU1201861249.SGD","HCSG","IE00B19Z3B42.SGD","LU1267930573.SGD","SBIO","LU0980610538.SGD","BK4588","IE00B64PRP62.GBP","LU0130517989.USD","XBI","BK4082","LU0310800379.SGD","LU0130102774.USD","LU0211328371.USD","LU0477156953.USD","LU1267930813.SGD","BK4137","BK4135","LU0310799852.SGD","IE00B19Z3581.USD","IE0002270589.USD","LABU","CGON","IE00BGHQF748.EUR","BK4139","IE00B3QW5Z07.USD","LU0211327993.USD","XLV","LU0128525929.USD","IE00B7SZLL34.SGD","GPZ","LU1267930490.SGD","LU0648001328.SGD","BK4581","BK4566","BK4585","LU0029874061.USD","BK4504","LU0889566641.SGD","CG","ZBH","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659184011","title":"Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659184011","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659184011?lang=en_us&edition=fundamental","pubTime":"2026-08-13 09:30","pubTimestamp":1786584613,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alto Neuroscience, Inc. (ANRO) and Owlet (OWLT) with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alto-neuroscience-inc-anro-and-owlet-owlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alto-neuroscience-inc-anro-and-owlet-owlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4082","ANRO","XBI","BK4137","BK4588","OWLT","LU0029874061.USD","HCSG","BK4585","LABU","LU0128526141.USD","XLV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659184077","title":"Belite Bio (BLTE) Is Up 12.9% After FDA Priority Review For Tinlarebant In Stargardt Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2659184077","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659184077?lang=en_us&edition=fundamental","pubTime":"2026-08-13 08:39","pubTimestamp":1786581542,"startTime":"0","endTime":"0","summary":"Belite Bio recently announced that the U.S. FDA has accepted and granted Priority Review to its New Drug Application for tinlarebant to treat Stargardt Disease Type 1, with a PDUFA target action date set for February 12, 2027.\nIf approved, tinlarebant would become the first FDA‑approved treatment for this rare inherited retinal disease, highlighting Belite Bio’s potential role in addressing a significant unmet medical need.\nWe will now examine how FDA Priority Review for tinlarebant, with a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blte/belite-bio/news/belite-bio-blte-is-up-129-after-fda-priority-review-for-tinl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blte/belite-bio/news/belite-bio-blte-is-up-129-after-fda-priority-review-for-tinl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BLTE","BK4588","BK4007","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":14,"totalSize":388,"code":"91000000","status":"200"}]}}